mortality/aging
• compared with Gt(ROSA)26Sortm2(sb11)Njen TgTn(sb-T2/Onc2)6070Njen mice
|
neoplasm
• greater than 90% of moribund mice develop tumors with an average latency of 46 weeks
|
• in one mouse
|
• in one mouse
|
• mice develop hematopoietic tumors including B cell, T cell, and myeloid tumors unlike Gt(ROSA)26Sortm2(sb11)Njen TgTn(sb-T2/Onc2)6070Njen mice that do not develop tumors
|
• 3 T cell lymphomas develop
|
• 2 myeloid leukemia tumors develop
|
• mice develop B cell lymphomas including diffuse large cell lymphomas and follicular lymphomas
• one mouse developed pre-B lymphoma
|
integument
• in one mouse
|
nervous system
• in one mouse
|
endocrine/exocrine glands
• 3 T cell lymphomas develop
|
immune system
• 3 T cell lymphomas develop
|
hematopoietic system
• 3 T cell lymphomas develop
|